Pancreatic cancer's physical appearance under a microscope reflects deep molecular differences — including in metastatic disease

Pancreatic cancer's physical appearance under a microscope reflects deep molecular differences — including in metastatic disease

Pancreatic ductal adenocarcinoma (PDAC) is typically stratified into 'basal-like' and 'classical' molecular subtypes, which carry different prognoses. But histological morphology — what the tumor looks like under a microscope — also varies significantly and may carry independent information.

This large study (348 patients) used laser-capture microdissection combined with whole-genome and transcriptome sequencing to characterize four morphological classes in PDAC: glandular, cribriform, solid, and squamous. The researchers analyzed both localized and metastatic tumors, finding that morphological class correlates with specific genomic and transcriptomic programs and has clinical relevance even in advanced disease.

The study provides the most detailed molecular characterization of PDAC morphological classes to date, suggesting that pathological assessment of tumor architecture could be a practical, low-cost biomarker that complements molecular subtyping — particularly useful in settings where expensive genomic testing isn't available.

Key Findings

• Four pancreatic cancer morphological classes (glandular, cribriform, solid, squamous) have distinct molecular underpinnings
• Morphological classification correlates with transcriptomic programs in both localized and metastatic PDAC
• Study included 348 patients with both early and advanced stage disease
• Laser-capture microdissection enabled precise molecular profiling of distinct tumor morphologies
• Morphological class provides prognostic information independent of standard clinical factors

Implications

Morphology-based classification of pancreatic cancer could serve as an accessible biomarker for treatment stratification, particularly in resource-limited settings where molecular testing isn't routine. If morphological class predicts response to specific therapies, this could immediately improve how patients are matched to treatments.

Caveats

Preprint, not peer reviewed. Retrospective study design. Laser-capture microdissection is labor-intensive, limiting scalability. Clinical utility of morphological classification for treatment decisions needs prospective validation. Summary based on abstract only.

Source: bioRxiv — 2026-04-10